BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 21280185)

  • 1. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.
    Leise MD; Kim WR; Kremers WK; Larson JJ; Benson JT; Therneau TM
    Gastroenterology; 2011 Jun; 140(7):1952-60. PubMed ID: 21334338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
    Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
    Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining a Liver Transplant Benefit Threshold for the Model for End-Stage Liver Disease-Sodium Score.
    Beal EW; Akateh C; Tumin D; Bagante F; Black SM; Washburn K; Azouley D; Pawlik TM
    Exp Clin Transplant; 2020 Aug; 18(4):491-497. PubMed ID: 31050611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
    Kim WR; Mannalithara A; Heimbach JK; Kamath PS; Asrani SK; Biggins SW; Wood NL; Gentry SE; Kwong AJ
    Gastroenterology; 2021 Dec; 161(6):1887-1895.e4. PubMed ID: 34481845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates.
    Sharma P; Schaubel DE; Gong Q; Guidinger M; Merion RM
    Hepatology; 2012 Jan; 55(1):192-8. PubMed ID: 21898487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
    Wong RJ; Gish RG; Ahmed A
    Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
    Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
    Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.
    Sharma P; Schaubel DE; Messersmith EE; Guidinger MK; Merion RM
    Liver Transpl; 2012 Dec; 18(12):1456-63. PubMed ID: 22965903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
    Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How much is too much?
    McCashland TM
    Liver Transpl; 2011 Feb; 17(2):102-3. PubMed ID: 21280181
    [No Abstract]   [Full Text] [Related]  

  • 14. A 10-Year united network for organ sharing review of mortality and risk factors in young children awaiting liver transplantation.
    Leung DH; Narang A; Minard CG; Hiremath G; Goss JA; Shepherd R
    Liver Transpl; 2016 Nov; 22(11):1584-1592. PubMed ID: 27541809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.
    Györi GP; Pereyra D; Rumpf B; Hackl H; Köditz C; Ortmayr G; Reiberger T; Trauner M; Berlakovich GA; Starlinger P
    Hepatology; 2020 Aug; 72(2):584-594. PubMed ID: 31773739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.
    Biselli M; Dall'Agata M; Gramenzi A; Gitto S; Liberati C; Brodosi L; Ravaioli M; Gambato M; Montalti R; Pinna AD; Burra P; Gerunda GE; Cillo U; Andreone P; Bernardi M
    Liver Int; 2015 Jan; 35(1):184-91. PubMed ID: 24650058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
    Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
    Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.
    Gotthardt D; Weiss KH; Baumgärtner M; Zahn A; Stremmel W; Schmidt J; Bruckner T; Sauer P
    BMC Gastroenterol; 2009 Sep; 9():72. PubMed ID: 19778459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.
    Atiemo K; Skaro A; Maddur H; Zhao L; Montag S; VanWagner L; Goel S; Kho A; Ho B; Kang R; Holl JL; Abecassis MM; Levitsky J; Ladner DP
    Am J Transplant; 2017 Sep; 17(9):2410-2419. PubMed ID: 28226199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantifying Sex-Based Disparities in Liver Allocation.
    Locke JE; Shelton BA; Olthoff KM; Pomfret EA; Forde KA; Sawinski D; Gray M; Ascher NL
    JAMA Surg; 2020 Jul; 155(7):e201129. PubMed ID: 32432699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.